Invitae Corporation (NVTA): Price and Financial Metrics

Invitae Corporation (NVTA): $0.02

0.00 (2.63%)

POWR Rating

Component Grades








NVTA Price/Volume Stats

Current price $0.02 52-week high $0.02
Prev. close $0.02 52-week low $0.02
Day low $0.02 Volume 6,533,000
Day high $0.02 Avg. volume 0
50-day MA $0.00 Dividend yield N/A
200-day MA $0.00 Market Cap 5.21M

NVTA Stock Price Chart Interactive Chart >

Invitae Corporation (NVTA) Company Bio

Invitae Corporation is a company that utilizes an integrated portfolio of laboratory processes, software tools and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for physicians and their patients. The company was founded in 2012 and is based in San Francisco, California.

NVTA Latest News Stream

Event/Time News Detail
Loading, please wait...

NVTA Latest Social Stream

Loading social stream, please wait...

View Full NVTA Social Stream

Latest NVTA News From Around the Web

Below are the latest news stories about INVITAE CORP that investors may wish to consider to help them evaluate NVTA as an investment opportunity.

Despite Fast-paced Momentum, Invitae (NVTA) Is Still a Bargain Stock

Invitae (NVTA) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Yahoo | December 22, 2023

Invitae Layoffs 2023: What to Know About the Latest NVTA Job Cuts

Invitae layoffs are a hot topic on Friday after the genetics company announced a 15% reduction of its workforce to reduce costs.

William White on InvestorPlace | December 15, 2023

Why Are Chinese Stocks Up Today?

Chinese stocks are up on Friday as investors react to recent economic data that includes signs of recovering in the reigon.

William White on InvestorPlace | December 15, 2023

Invitae Divests Ciitizen Health Data Platform and Implements Further Cost Cuts

Invitae (NYSE: NVTA), a leading medical genetics company, today announced strategic changes to streamline operations and reduce operating cash burn. The company has divested the assets of Ciitizen and announced strategic cost cuts, which will include a workforce reduction and other operating expense reductions.

Yahoo | December 13, 2023

What Makes Invitae (NVTA) a New Buy Stock

Invitae (NVTA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Yahoo | December 13, 2023

Read More 'NVTA' Stories Here

NVTA Price Returns

1-mo N/A
3-mo N/A
6-mo -97.22%
1-year -98.35%
3-year -99.94%
5-year -99.91%
YTD -96.81%
2023 -66.30%
2022 -87.82%
2021 -63.48%
2020 159.21%
2019 45.84%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!